Minoxidil

CHEMBL802 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
209.2 g/mol
LogP
1.2
Phase
4

This medication relaxes and widens blood vessels to lower blood pressure, and in topical form it stimulates hair follicles to promote hair regrowth. It is used orally for severe hypertension and applied to the scalp to treat hair loss.

Peso molecular

209,2500 g/mol

LogP

1,20

TPSA

88,90 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Mecanismo de acción

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]

InChI

InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H2,11,12)

Molecular Formula

C9H15N5O

HBD / HBA

3 / 3

Enlaces Rotables

1

Átomos Pesados

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This medication relaxes and widens blood vessels to lower blood pressure, and in topical form it stimulates hair follicles to promote hair regrowth. It is used orally for severe hypertension and applied to the scalp to treat hair loss.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Minoxidil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL802. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4201. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.